publication date: Jan. 24, 2014


The Community Oncology Alliance and the American Society of Clinical Oncology issued a joint statement on payment reform in cancer care and proposed alternative approaches to paying for cancer care.

The Jan. 22 statement by the two organizations, as well as AmerisourceBergen/ION and McKesson/US Oncology, said they had agreed on principles for changing the health care payment systems to emphasize high-quality, high-value cancer care.

“Traditional reimbursement models currently do not provide adequate support for the care coordination and complex disease management necessary for delivery of high quality, high value care in oncology,” the two organizations said in the statement.

“Improving the quality and value of the care provided to individuals with cancer may require changes that ensure adequate financial, administrative and data support for oncology providers to engage in new approaches that reduce the frequency and severity of clinical complications.”

The groups propose two approaches as alternatives to the existing system:

• Oncology Medical Home (developed by COA). Investing in changes to clinical practices and operations under an oncology medical home model can improve the quality of care and significantly reduce the aggregate costs of cancer care by reducing the frequency of avoidable complications, emergency department visits and unscheduled hospitalizations.

Adopting the oncology medical home requires investment in information technology infrastructure and other practice support to provide the full range of services needed by patients with cancer—throughout the course of their treatment and transition to survivorship.

This four-phase, five-year payment reform model would … Continue reading 40-04 Capitol Hill

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.